SPEPHARM NORDIC ApS: Financial statements 2012
CVR: 31176786
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
SPEPHARM NORDIC ApS (CVR 31176786) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 155,378 and a net result of DKK 14,291. Equity in the 2012 report amounted to DKK 90,249. The solvency ratio was 67.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 155,378
- Profit/Loss
- DKK 14,291
- Equity
- DKK 90,249
- Total Assets
- DKK 133,931
- Employees
- 1
Official annual report
Keep an eye on SPEPHARM NORDIC ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 14, 2012, Peter Legarth Petersen is registered as direktion of SPEPHARM NORDIC ApS.
As of December 14, 2012, Nancy Elisa Janssens is registered as direktion of SPEPHARM NORDIC ApS.
As of December 14, 2012, Jean-Francois Labbe has stepped down as direktion of SPEPHARM NORDIC ApS.
As of December 14, 2012, Johannes Vos has stepped down as direktion of SPEPHARM NORDIC ApS.
About SPEPHARM NORDIC ApS
SPEPHARM NORDIC ApS was a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2008. The company has been dissolved on 13 March 2014. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2012). In 2012, the company reported a gross profit of DKK 155,378 and a net result of DKK 14,291. Equity in the 2012 report amounted to DKK 90,249.